<DOC>
	<DOC>NCT01874613</DOC>
	<brief_summary>Bioactive fibre-reinforced composite implant is used for reconstruction of skull bone defects and orbital floor defects. Functional and aesthetic outcome is assessed by patient and doctor.</brief_summary>
	<brief_title>Clinical Study of FRC Implant to Treat Skull Bone Defects</brief_title>
	<detailed_description>Development phase: Clinical trial Objectives: Assessment of functional and aesthetic outcome Methodology: Intervention study Sample size: 35+20+25 Main criteria for inclusion: Skull bone defect OR orbital floor fracture Investigational drug/treatment, dose and mode of administration: FRC implant Comparative drug(s)/placebo/treatment, dose and mode of administration: - Duration of treatment: 2 years of follow-up Assessments: Clinical outcome and radiologic assesment Functional and aesthetic outcome with Visual Analog Scale (VAS). Pain assessment with VAS. Statistical methods: Adequate statistical methods for publishing in international peer-reviewed journals.</detailed_description>
	<criteria>Study arm 1: patients with skull bone defect reconstruction indications fullfilled Study arm 2: patients with orbital floor defect reconstruction indication fullfilled if informed consent cannot be obtained</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Craniofacial bone reconstruction</keyword>
	<keyword>Fibre-reinforced composite</keyword>
	<keyword>Bioactive glass</keyword>
	<keyword>Craniotomy</keyword>
	<keyword>Skull bone defect</keyword>
</DOC>